U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Substance Class Protein
Created
by admin
on Sat Dec 16 17:34:17 GMT 2023
Edited
by admin
on Sat Dec 16 17:34:17 GMT 2023
Protein Type ENZYME
Protein Sub Type METALLOPROTEASE
Sequence Origin HUMAN
Sequence Type COMPLETE
Record UNII
U5SFU33XUX
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
Apadamtase Alfa
INN  
Official Name English
ADAMTS13 Q23, recombinant
Preferred Name English
rADAMTS13 Q23
FDA  
Preferred Name English
rADAMTS-13 Q23
Code English
A DISINTEGRIN AND METALLOPROTEINASE WITH THROMBOSPONDIN MOTIFS 13 (RECOMBINANT)
Common Name English
Metalloproteinase ADAMTS13 (human recombinant BAX930)
Common Name English
Native rADAMTS13 Q23
Common Name English
RECOMBINANT HUMAN ADAMTS13
Common Name English
BAX930
Code English
Apadamtase alfa [WHO-DD]
Common Name English
SHP655
Code English
apadamtase alfa [INN]
Common Name English
RECOMBINANT ADAMTS-13
Common Name English
ADAMTS13 Q23, RECOMBINANT HUMAN
Common Name English
human metalloproteinase with thrombospondin motifs 13 (metalloproteinase ADAMTS13), produced in Chinese hamster ovary (CHO) cells, glycoform alfa
Common Name English
SHP-655
Code English
RECOMBINANT-A DISINTEGRIN AND MELLATOPROTEINASE WITH THROMBOSPONDIN TYPE-1 MOTIFS-13
Common Name English
BAX-930
Code English
TAK755
Code English
TAK-755
Code English
Classification Tree Code System Code
FDA ORPHAN DRUG 262208
Created by admin on Sat Dec 16 17:34:18 GMT 2023 , Edited by admin on Sat Dec 16 17:34:18 GMT 2023
EU-Orphan Drug EU/3/08/588
Created by admin on Sat Dec 16 17:34:18 GMT 2023 , Edited by admin on Sat Dec 16 17:34:18 GMT 2023
FDA ORPHAN DRUG 265208
Created by admin on Sat Dec 16 17:34:18 GMT 2023 , Edited by admin on Sat Dec 16 17:34:18 GMT 2023
FDA ORPHAN DRUG 768720
Created by admin on Sat Dec 16 17:34:18 GMT 2023 , Edited by admin on Sat Dec 16 17:34:18 GMT 2023
Code System Code Type Description
CAS
2086325-24-6
Created by admin on Sat Dec 16 17:34:18 GMT 2023 , Edited by admin on Sat Dec 16 17:34:18 GMT 2023
PRIMARY
FDA UNII
U5SFU33XUX
Created by admin on Sat Dec 16 17:34:18 GMT 2023 , Edited by admin on Sat Dec 16 17:34:18 GMT 2023
PRIMARY
USAN
KL-66
Created by admin on Sat Dec 16 17:34:18 GMT 2023 , Edited by admin on Sat Dec 16 17:34:18 GMT 2023
PRIMARY
INN
10765
Created by admin on Sat Dec 16 17:34:18 GMT 2023 , Edited by admin on Sat Dec 16 17:34:18 GMT 2023
PRIMARY
WIKIPEDIA
ADAMTS13
Created by admin on Sat Dec 16 17:34:18 GMT 2023 , Edited by admin on Sat Dec 16 17:34:18 GMT 2023
PRIMARY
NCI_THESAURUS
C169784
Created by admin on Sat Dec 16 17:34:18 GMT 2023 , Edited by admin on Sat Dec 16 17:34:18 GMT 2023
PRIMARY
DRUG BANK
DB15164
Created by admin on Sat Dec 16 17:34:18 GMT 2023 , Edited by admin on Sat Dec 16 17:34:18 GMT 2023
PRIMARY
From To
1_81 1_134
1_128 1_207
1_168 1_191
1_237 1_263
1_248 1_273
1_258 1_292
1_286 1_297
1_322 1_359
1_326 1_364
1_337 1_349
1_376 1_413
1_409 1_448
1_434 1_453
1_458 1_474
1_471 1_481
Glycosylation Type MAMMALIAN
Glycosylation Link Type Site
N 1_68
N 1_72
N 1_478
N 1_505
N 1_540
N 1_593
N 1_633
N 1_754
N 1_1161
N 1_1280
O 1_325
O 1_624
O 1_683
O 1_833
O 1_891
O 1_953
O 1_1013
Related Record Type Details
SUBSTRATE->ENZYME
TARGET -> SUBSTRATE
ADAMTS-13 (a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13) is a constitutively active enzyme that cleaves von Willebrand factor (VWF) at the Tyr1605–Met1606 bond in the A2 domai
TARGET -> INHIBITOR
Related Record Type Details
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
MOL_WEIGHT CHEMICAL
Molecular Formula CHEMICAL